Skip to main content
. 2021 Oct 8;28:10732748211040013. doi: 10.1177/10732748211040013

Figure 4.

Figure 4.

Treatment duration for BRAF V600E-mutant gliomas treated with targeted therapy. Patients were treated with dabrafenib plus trametinib. Patient cases #1 and #2 had chloroquine added to their regimen at approximately 9 months and 14 months, respectively. Patient cases #3 and #4 are ongoing with treatment at 16 months and 53 months, respectively.